Biocon Market Cap

Biocon has a market cap or net worth of 587.14 billion as of April 28, 2026. Its market cap has increased by 49.66% in one year.

Market Cap

587.14B

Enterprise Value

753.98B

Revenue

168.27B

Ranking

n/a

PE Ratio

97.18

Stock Price

362.80

Market Cap Chart

Since April 7, 2004, Biocon's market cap has increased from 45.41B to 587.14B, an increase of 1,192.90%. That is a compound annual growth rate of 12.30%.

Market Cap History

Date	Market Cap	% Change
Apr 28, 2026	587.14B	11.70%
Dec 31, 2025	525.64B	20.22%
Dec 31, 2024	437.25B	46.69%
Dec 29, 2023	298.08B	-4.59%
Dec 30, 2022	312.41B	-27.97%
Dec 31, 2021	433.73B	-21.37%
Dec 31, 2020	Pro	Pro
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Aarti Drugs	33.46B
Titan Biotech	19.35B
Hester Biosciences	12.74B
CCME Global	4.93B
Zenotech Laboratories	2.85B
Bharat Immunologicals & Biologicals Corporation	762.99M
Transgene Biotek	217.46M
Hindustan Bio Sciences	96.67M

Market Cap Rankings